Genetic Technologies Ltd. (GENE)

2.10
0.08 3.67
NASDAQ : Health Technology
Prev Close 2.18
Open 2.17
Day Low/High 2.02 / 2.22
52 Wk Low/High 1.56 / 6.32
Volume 38.20K
Avg Volume 96.90K
Exchange NASDAQ
Shares Outstanding 4.90M
Market Cap 10.10M
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)
Interesting GENE Call For February 2014

Interesting GENE Call For February 2014

Investors in Genetic Technologies Ltd. saw new options become available today, for the February 2014 expiration.

STUDY VALIDATES BREVAGen MORE ACCURATELY IDENTIFIES BREAST CANCER RISK LEADING TO INCREASED BREAST HEALTH COMPLIANCE

STUDY VALIDATES BREVAGen MORE ACCURATELY IDENTIFIES BREAST CANCER RISK LEADING TO INCREASED BREAST HEALTH COMPLIANCE

Phenogen Sciences, Inc. Presented Study Results at the 23rd Annual National Interdisciplinary Breast Center Conference

The Centers For Women's Health In Stamford CT Pioneers Breast Cancer Risk Assessment

The Centers For Women's Health In Stamford CT Pioneers Breast Cancer Risk Assessment

Local Physician One of the First in Nation to Use New Breast Cancer Predictive Risk Test

5 Stocks Ready to Break Out

5 Stocks Ready to Break Out

These stocks look poised to break out and trade higher from current levels.

4 Stocks Under $10 Making Big Moves

4 Stocks Under $10 Making Big Moves

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

4 Biotech Stocks Under $10 Soaring Higher

4 Biotech Stocks Under $10 Soaring Higher

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

BREVAGen Reclassified 64% Of Intermediate Gail Risk Subjects(1) (Graphic: Business Wire)

BREVAGen Reclassified 64% Of Intermediate Gail Risk Subjects(1) (Graphic: Business Wire)

Dr. Owen Winsett of the Breast Center of Austin is one of the first physicians in the nation to make the BREVAGen™ predictive risk test available to his patients.

8 Stocks Under $10 Ripping Higher

8 Stocks Under $10 Ripping Higher

When a stock makes a large percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Break-Through Invention For Treating Cancer

Break-Through Invention For Treating Cancer

ImmunAid Pty. Ltd.

Genetic Technologies Limited Announces Quarterly Activities Report For The Quarter Ended 30 September 2011

Genetic Technologies Limited Announces Quarterly Activities Report For The Quarter Ended 30 September 2011

Genetic Technologies Limited (ASX: GTG, NASDAQ: GENE) today reported their quarterly activities report for the quarter ended 30 September, 2011.

Genetic Technologies’ BREVAGen™ Changing The Way US Physicians Assess Breast Cancer Risk

Genetic Technologies’ BREVAGen™ Changing The Way US Physicians Assess Breast Cancer Risk

Genetic Technologies Limited (ASX: GTG, NASDAQ: GENE) today reported early insights from the US regional launch of BREVAGen™, its new, easy-to-use, predictive risk test for the tens of millions of women at ...

Genetic Technologies Limited Appoints Dr. Mervyn Cass As Company Director

Genetic Technologies Limited Appoints Dr. Mervyn Cass As Company Director

The Board of Directors of Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) has with great pleasure appointed Dr.

Optimer Soars on Antibiotic Data

Optimer Soars on Antibiotic Data

Optimer Pharmaceuticals proves that even in a bear market, small biotech stocks are still capable of doubling in price overnight.

Ties May Bind Apple's CEO to Board

Ties May Bind Apple's CEO to Board

Analysts ponder the state of independence of a board handpicked by Steve Jobs.

Wednesday's Small-Cap Winners & Losers

Wednesday's Small-Cap Winners & Losers

Systemax jumps, but Travelzoo declines.